Updates are available Correction dated 2021-11-03
Click to view Correction: https://doi.org/10.1186/s10194-021-01342-3
-
Authors
Bottiroli, Sara
De Icco, Roberto
Vaghi, Gloria
Pazzi, Stefania
Guaschino, Elena
Allena, Marta
Ghiotto, Natascia
Martinelli, Daniele
Tassorelli, Cristina
Sances, Grazia
- License Information
-
More Information
Article History
Received: 5 August 2021
Accepted: 22 September 2021
First Online: 2 October 2021
Change Date: 3 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s10194-021-01342-3
Declarations
:
: The study was performed in accordance with the guidelines of the Declaration of Helsinki. Authors obtained local ethics committee (San Matteo Hospital, Pavia, Italy) approval of the protocol, which was registered at ClinicalTrials.gov (NCT04361721). All patients provided written informed consent in advance of study participation.
: Not applicable.
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: CT received honoraria for the participation in advisory boards or for lecturing from: Allergan, Eli-Lilly, Novartis, and Teva. CT and GS has no ownership interest and does not own stocks of any pharmaceutical company. CT is on the editorial board of The Journal of Headache and Pain. GS received honoraria for the participation in advisory boards or for lecturing from: Eli-Lilly, Novartis, and Teva. The remaining authors have no conflicts of interest.
